当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析

瑞康医药

(002589)

  

流通市值:39.33亿  总市值:43.34亿
流通股本:13.66亿   总股本:15.05亿

瑞康医药(002589)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.27亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益545418.01万元,未分配利润25421.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1532895.40万元,负债987477.40万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,406,533,649.773,543,520,195.091,756,650,456.757,966,345,576.74
营业总成本5,455,252,955.233,627,527,911.61,764,616,859.728,019,365,853.25
其他经营收益
营业利润16,527,171.53-18,818,843.9823,679,569.8525,532,765.3
利润总额4,545,017.87-15,385,259.8923,391,966.5841,568,837.58
净利润27,004,113.830,605,041.8819,435,375.8741,017,810.26
每股收益
其他综合收益----
综合收益总额27,004,113.830,605,041.8819,435,375.8741,017,810.26
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计10,443,029,336.1412,337,954,409.8211,156,915,614.3111,083,869,928.27
非流动资产:
非流动资产合计4,885,924,680.644,950,681,606.724,883,421,251.534,953,602,020.09
资产总计15,328,954,016.7817,288,636,016.5416,040,336,865.8416,037,471,948.36
流动负债:
流动负债合计9,398,039,209.2211,259,033,370.419,938,781,889.059,944,343,968.44
非流动负债:
非流动负债合计476,734,746.18463,677,272.39412,702,208.39384,438,086.22
负债合计9,874,773,955.411,722,710,642.810,351,484,097.4410,328,782,054.66
所有者权益(或股东权益):
归属于母公司股东权益合计5,348,973,670.935,355,003,490.145,509,105,629.985,548,487,656.81
股东权益合计5,454,180,061.385,565,925,373.745,688,852,768.45,708,689,893.7
负债和股东权益合计15,328,954,016.7817,288,636,016.5416,040,336,865.8416,037,471,948.36
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,192,029,131.794,055,813,851.781,956,956,780.759,594,898,625.86
经营活动现金流出小计6,151,452,949.13,987,927,753.241,913,930,631.999,434,453,746.36
经营活动产生的现金流量净额40,576,182.6967,886,098.5443,026,148.76160,444,879.5
投资活动产生的现金流量:
投资活动现金流入小计372,374,297.38231,494,480.4225,039,560.231,061,548,202.41
投资活动现金流出小计499,479,265.73367,126,743.9624,396,079.85857,570,822.17
投资活动产生的现金流量净额-127,104,968.35-135,632,263.54643,480.38203,977,380.24
筹资活动产生的现金流量:
筹资活动现金流入小计13,337,365,337.149,128,738,056.045,436,577,590.8321,358,688,268.97
筹资活动现金流出小计13,450,865,255.428,982,804,795.215,196,928,207.0421,505,163,072.91
筹资活动产生的现金流量净额-113,499,918.28145,933,260.83239,649,383.79-146,474,803.94
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-200,028,703.9478,187,095.83283,319,012.93217,947,455.8
期末现金及现金等价物余额490,294,222.13768,510,021.9973,208,371.46689,889,358.53
补充资料:
现金及现金等价物的净增加额-78,187,095.83-217,947,455.8
TOP↑